JP2011500693A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500693A5
JP2011500693A5 JP2010530049A JP2010530049A JP2011500693A5 JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5 JP 2010530049 A JP2010530049 A JP 2010530049A JP 2010530049 A JP2010530049 A JP 2010530049A JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5
Authority
JP
Japan
Prior art keywords
methyl
bipyrrolidinyl
phenyl
amide
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530049A
Other languages
English (en)
Japanese (ja)
Other versions
JP5377503B2 (ja
JP2011500693A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079757 external-priority patent/WO2009052062A1/en
Publication of JP2011500693A publication Critical patent/JP2011500693A/ja
Publication of JP2011500693A5 publication Critical patent/JP2011500693A5/ja
Application granted granted Critical
Publication of JP5377503B2 publication Critical patent/JP5377503B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530049A 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用 Expired - Fee Related JP5377503B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98059907P 2007-10-17 2007-10-17
US60/980,599 2007-10-17
PCT/US2008/079757 WO2009052062A1 (en) 2007-10-17 2008-10-14 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof

Publications (3)

Publication Number Publication Date
JP2011500693A JP2011500693A (ja) 2011-01-06
JP2011500693A5 true JP2011500693A5 (OSRAM) 2011-12-01
JP5377503B2 JP5377503B2 (ja) 2013-12-25

Family

ID=40247942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530049A Expired - Fee Related JP5377503B2 (ja) 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用

Country Status (25)

Country Link
US (2) US8088808B2 (OSRAM)
EP (1) EP2212283B1 (OSRAM)
JP (1) JP5377503B2 (OSRAM)
KR (1) KR20100072077A (OSRAM)
CN (1) CN101903340B (OSRAM)
AT (1) ATE525351T1 (OSRAM)
AU (1) AU2008312635B2 (OSRAM)
BR (1) BRPI0818581A2 (OSRAM)
CA (1) CA2702467C (OSRAM)
CY (1) CY1112083T1 (OSRAM)
DK (1) DK2212283T3 (OSRAM)
ES (1) ES2372332T3 (OSRAM)
HR (1) HRP20110762T1 (OSRAM)
IL (1) IL205001A (OSRAM)
MA (1) MA31858B1 (OSRAM)
MX (1) MX2010003949A (OSRAM)
MY (1) MY151348A (OSRAM)
NZ (1) NZ584690A (OSRAM)
PL (1) PL2212283T3 (OSRAM)
PT (1) PT2212283E (OSRAM)
RS (1) RS52235B (OSRAM)
RU (1) RU2477720C2 (OSRAM)
SI (1) SI2212283T1 (OSRAM)
WO (1) WO2009052062A1 (OSRAM)
ZA (1) ZA201002115B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818626A2 (pt) 2007-10-17 2015-09-29 Sanofi Aventis n-fenil-bipirrolidina carboxamidas substituída e uso terapêutico da mesma
SI2215058T1 (sl) 2007-10-17 2012-03-30 Sanofi Sa Substituirane N fenil bipirolidin sečnine in njihova terapevtska uporaba
SI2212283T1 (sl) * 2007-10-17 2011-12-30 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
AU2008312636B2 (en) 2007-10-17 2013-03-14 Sanofi-Aventis Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
AR074467A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Tetrahidropiran espiro pirrolidinonas y piperidinonas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento y/o prevencion de enfermedades del snc ,tales como alzheimer y parkinson, entre otras.
AR074466A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
SA110310332B1 (ar) * 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
WO2011143162A1 (en) * 2010-05-11 2011-11-17 Sanofi Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
TW201206910A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
AR083718A1 (es) 2010-05-11 2013-03-20 Sanofi Aventis Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas
JP5833105B2 (ja) * 2010-05-11 2015-12-16 サノフイ 置換n−ヘテロアリールスピロラクタムビピロリジン類、その製造及び治療的使用
EP2569296A1 (en) * 2010-05-11 2013-03-20 Sanofi Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
TW201206444A (en) * 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
JP5766278B2 (ja) 2010-05-11 2015-08-19 サノフイ 置換されたn−アルキルおよびn−アシルテトラヒドロ−イソキノリン誘導体、それらの製造および治療上の使用
ES2527466T3 (es) * 2010-07-06 2015-01-26 Astrazeneca Ab Agentes terapéuticos 976
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
JP2013232564A (ja) * 2012-04-27 2013-11-14 National Institute Of Advanced Industrial & Technology 半導体装置および半導体装置の製造方法
CN103694163A (zh) * 2012-09-27 2014-04-02 上海先声药物研究有限公司 作为钾通道调节剂的化合物
EA201500736A1 (ru) 2013-01-10 2016-04-29 Грюненталь Гмбх Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
HK1216301A1 (zh) 2013-01-10 2016-11-04 Grünenthal GmbH 作为crac通道抑制剂的基於吡唑基的甲醯胺ii
EP3366683A1 (en) 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
CA2504272A1 (en) * 2002-10-23 2004-05-06 Janssen Pharmaceutica, N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN101142180B (zh) 2005-03-17 2011-05-04 伊莱利利公司 作为组胺h3受体拮抗剂的吡咯烷衍生物
CA2602234C (en) * 2005-04-01 2014-01-14 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
WO2007005503A1 (en) * 2005-07-01 2007-01-11 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
WO2007048595A1 (en) * 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
EP1987020B1 (en) * 2006-02-15 2012-10-03 Sanofi Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
SI2212283T1 (sl) * 2007-10-17 2011-12-30 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
SI2215058T1 (sl) 2007-10-17 2012-03-30 Sanofi Sa Substituirane N fenil bipirolidin sečnine in njihova terapevtska uporaba
AU2008312636B2 (en) 2007-10-17 2013-03-14 Sanofi-Aventis Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
BRPI0818626A2 (pt) 2007-10-17 2015-09-29 Sanofi Aventis n-fenil-bipirrolidina carboxamidas substituída e uso terapêutico da mesma

Similar Documents

Publication Publication Date Title
JP2011500693A5 (OSRAM)
CA2702467A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
CA2702482A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
RU2010119530A (ru) Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
JP2005526723A5 (OSRAM)
JP2010526777A5 (OSRAM)
JP2011500697A5 (OSRAM)
RU2462456C2 (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2013518881A5 (OSRAM)
JP2011500694A5 (OSRAM)
JP2005527579A5 (OSRAM)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
RU2011137454A (ru) Агонисты и антагонисты s1p5-рецепторов и способы их применения
JP2002539206A5 (OSRAM)
CN109503625A (zh) 一种多环吡啶酮化合物及其药物组合和用途
JP2007508358A5 (OSRAM)
JP2006522126A5 (OSRAM)
JP2012515724A5 (OSRAM)
JP2010502716A5 (OSRAM)
JP2007508360A5 (OSRAM)
JP2012507538A5 (OSRAM)
BR112012015168A2 (pt) "derivados de benzamida substituída".
JP2020527175A5 (OSRAM)
JP2011527333A5 (OSRAM)
JP2013506637A5 (OSRAM)